BASIC SCIENCE
Induction of left ventricular remodeling and dysfunction in the recipient heart after donor heart myocardial infarction
new insights into the pathologic role of tumor necrosis factor-alpha from a novel heterotopic transplantcoronary ligation rat model
Hiroshi Nakamura, MD, PhD*,*,
Seiji Umemoto, MD, PhD*,
George Naik, BSc ,
Gordon Moe, MD, FACC ,
Satoko Takata, MD*,
Peter Liu, MD, FACC and
Masunori Matsuzaki, MD, PhD, FACC*
* Department of Cardiovascular Medicine, Yamaguchi University School of Medicine, Ube, Japan
St. Michaels Hospital, Toronto, Canada
Centre for Cardiovascular Research, The Toronto Hospital, and University of Toronto, Toronto, Canada
Manuscript received October 29, 2002;
revised manuscript received March 22, 2003,
accepted March 27, 2003.
* Reprint requests and correspondence: Dr. Hiroshi Nakamura, Department of Cardiovascular Medicine, Yamaguchi University School of Medicine, 1-1-1 Minami-kogushi, Ube, Yamaguchi, 755-8505 Japan. nahirosi{at}yamaguchi-u.ac.jp
OBJECTIVES: The present study investigated the effects of tumor necrosis factor (TNF)-alpha and angiotensin II (ANG II) on cardiac remodeling and dysfunction at the early stage of acute myocardial infarction (MI) by using a novel heterotopic cardiac transplantationcoronary ligation model.
BACKGROUND: A recent clinical study has demonstrated a possible role of monocytosis in the development of left ventricular (LV) remodeling in patients with acute MI reperfusion.
METHODS: We performed isogenic heterotopic cardiac transplantation and simultaneous coronary ligation to produce MI in the donor heart and to evaluate the hearts of both donors and recipients in Lewis rats.
RESULTS: A significant decrease in LV fractional shortening and positive rate of rise in LV pressure and a significant increase in LV end-diastolic dimension/body weight and LV end-diastolic pressure were observed in the recipient hearts in the ligation group on day 7. TNF-alpha was significantly elevated not only in the plasma but also in the recipient hearts in the ligation group. In contrast, ANG II was significantly increased only in the infarct region of the donor hearts, but not in the plasma. Furthermore, the recipients transient LV remodeling and dysfunction were completely abolished by the intravenous administration of a TNF-alpha antagonist.
CONCLUSIONS: We developed a novel cardiac transplantationcoronary ligation model capable of inducing MI in the absence of downstream hemodynamic effects and allowing differential quantification of indexes of cardiac remodeling in vivo, including the local and remote effects of ANG II and TNF-alpha on cardiac remodeling.
|
Abbreviations and Acronyms
| | ACE | | angiotensin-converting enzyme | | ANG II | | angiotensin II | | dP/dt | | rate of rise in left ventricular pressure | | FS | | fractional shortening | | HF | | heart failure | | HR | | heart rate | | LV | | left ventricular | | LVEDD | | left ventricular end-diastolic dimension | | LVEDP | | left ventricular end-diastolic pressure | | LVESD | | left ventricular end-systolic dimension | | MCP | | monocyte chemoattractant protein | | MI | | myocardial infarction | | TNF | | tumor necrosis factor | | TNFR:Fc | | tumor necrosis factor-alpha receptor antagonist | | WBC | | white blood cell |
|
This article has been cited by other articles:

|
 |

|
 |
 
M. Nian, P. Lee, N. Khaper, and P. Liu
Inflammatory Cytokines and Postmyocardial Infarction Remodeling
Circ. Res.,
June 25, 2004;
94(12):
1543 - 1553.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|